AstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumors
Plus news about ImmunityBio, Modus Therapeutics and Hyperway Pharmaceutical. AstraZeneca strikes AI drug discovery deal with insitro: The pharma giant will pay the California-based company $40 million upfront. In return, insitro's ...
October 15, 2026 11:30 AM EDT News Briefing AstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumors ENDPOINTS Plus news about ImmunityBio, Modus Therapeutics and Hyperway Pharmaceutical. AstraZeneca strikes AI drug discovery deal with insitro: The pharma giant will … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that